Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma.

Metwaly Ibrahim MortadaDoaa ShahinNashwa AbousamraDoaa Abdalla AladleShaimaa El-AshwahF E I GhobrialM A El-BaiomyEman A SolimanNermeen A NiazyMayada A Ghannam

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Our research demonstrated that IL-17A polymorphism may not be linked to multiple myeloma susceptibility in our population and did not influence its different clinical and laboratory features. IL-17A polymorphism had no effect on OS in MM patients.

Keyphrases

multiple myeloma
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
copy number
patient reported